Periodic Reporting in Egypt: PMSR, PSUR and PSR Requirements under the Vigilance Guideline

1. Key takeaways

Periodic reporting in Egypt is built as a three-layer structure with class-differentiated frequencies. The first layer, the Post-Market Surveillance Report (PMSR), is prepared by manufacturers of Class I devices and Class A (or equivalently classified) IVDs; it summarises the analysis and conclusions drawn from post-market surveillance data, describes any preventive and corrective actions taken and the rationale for them, is updated when necessary and is provided upon request of the competent authority. The second layer, the Periodic Safety Update Report (PSUR), applies to Class IIa, IIb and III devices and Class B, C and D (or equivalently classified) IVDs, and must be accompanied by a national appendix. The third layer, the Periodic Summary Report (PSR, Annex 9), may replace case-by-case serious incident reporting where the root cause has been identified or a field safety corrective action has been implemented, or where the incidents are common and well documented, subject to MDSU agreement on format, content and frequency.

2. Legal basis

The periodic reporting obligations all sit within the vigilance guideline, across its PMSR, PSUR and PSR clauses and the associated annexes.

3. Expert insights

Insight 1: PSUR update frequencies run in three class-based tiers, not a uniform annual cycle.

Item 3: Class IIb and III devices, and Class C and D (or equivalently classified) IVDs, must be updated and submitted at least annually. Item 4: Class IIa devices are submitted when necessary, and at least every 2 years. Item 5: Class B (or equivalently classified) IVDs are submitted when necessary, and at least every 3 years. When building a periodic reporting calendar, companies must schedule by classification and cannot simply process everything on an annual rhythm.

Insight 2: PSUR content is three-part and linked to the post-market surveillance plan.

The PSUR must set out: (a) the conclusion of the benefit-risk determination; (b) the main findings of PMCF and PMPF; and (c) the device sales volume, together with an assessment of the size and other characteristics of the population using the device and, where feasible, the usage frequency. The guideline further requires that the PSUR be aligned with the post-market surveillance plan, the risk management plan, the PMCF and PMPF plans, and the clinical evaluation plan.

Insight 3: the PSUR must be accompanied by a national appendix and a declaration.

Item 1 requires that the PSUR be submitted with a national appendix for each device, and, where appropriate, by device category or device group. Reading this against the annex structure of the guideline, the national appendix corresponds to Annex 4 and the declaration to Annex 5. As a practical estimate, the exact form numbers and completion requirements should be confirmed against the current annex texts of the guideline.

Insight 4: custom-made devices have their own rule.

Item 6 provides that PSURs for custom-made devices are submitted annually or every 2 years according to their classification. Many markets exclude custom-made devices from periodic reporting altogether; Egypt expressly brings them within scope, which surprises companies used to the European pattern.

Insight 5: the trigger conditions for the PSR are an identified root cause or an implemented FSCA.

The PSR clause provides that for similar serious incidents involving the same device or device type, where the root cause has been identified or a field safety corrective action has been implemented, or where the incidents are common and well documented, the manufacturer may provide a Periodic Summary Report (PSR, Annex 9) in place of case-by-case serious incident reports, provided that MDSU has agreed with the manufacturer on the format, content and frequency of the report.

Insight 6: approval to switch to the PSR in other countries must be notified to MDSU.

The clause states explicitly that where a manufacturer has already obtained the agreement of the competent authorities of other countries to move to periodic summary reporting, that agreement and its modalities shall be notified to MDSU. This is an information-synchronisation duty, not automatic recognition of the foreign arrangement.

Insight 7: the PSR may use the latest European Commission format.

The guideline notes that manufacturers may use the most recent PSR format approved by the European Commission. For companies that already maintain European Union vigilance documentation, this is a substantive simplification that avoids building a parallel Egyptian format from scratch.

Insight 8: events already covered by an FSN no longer need case-by-case reports.

The first item of the clause on what must be reported periodically by PSR states that incidents described in a field safety notice that occur after the manufacturer has published the FSN and implemented the field safety corrective action need not be reported case by case. The manufacturer may agree the frequency and content of a periodic summary report with MDSU, and that report must be sent to all affected national competent authorities.

4. Practical recommendations

A workable periodic reporting programme rests on scheduling discipline and document linkage.

1. Build the periodic reporting calendar by classification: PMSR (Class I / Class A), PSUR annually (IIb/III, C/D), every 2 years (IIa), and every 3 years (Class B).
2. Prepare each PSUR in three parts: benefit-risk conclusion, main PMCF/PMPF findings, and sales volume with user-population assessment.
3. Attach a national appendix to every PSUR, and confirm the current declaration form version.
4. Update the PSUR in step with the PMS plan, risk management plan, PMCF/PMPF plans and clinical evaluation plan.
5. Schedule custom-made devices into the annual or two-year cycle according to their classification.
6. Assess repeated incidents for a switch to the PSR: first reach agreement with MDSU on format, content and frequency.
7. Notify MDSU of PSR permissions granted abroad; use the latest European Commission PSR format where possible.

5. Verification checklist

• □ The report type (PMSR / PSUR / PSR) has been determined for each classification
• □ PSUR frequencies are scheduled by class: annually (IIb/III, C/D) / every 2 years (IIa) / every 3 years (Class B)
• □ The three PSUR content elements (benefit-risk, PMCF/PMPF, sales volume and user population) are templated
• □ The national appendix (Annex 4) and declaration (Annex 5) are attached
• □ The PSUR is linked to the PMS, risk management, PMCF and clinical evaluation plans
• □ Custom-made devices are scheduled into their corresponding cycles
• □ PSR use has been agreed with MDSU on format, content and frequency
• □ PSR permissions obtained abroad have been notified to MDSU

Regulatory information verified as of October 29, 2026. The periodic reporting requirements listed in this article follow the current text of EDREX: GL.CAP.Care.040 Version 1 (published November 2025).

• Egypt local support: GRZAN assists manufacturers from the Chinese mainland and overseas with EDA medical device registration, import approval and variation applications, including registration applicant pathway design (importing company, local factory, or Scientific Office), preparation for Scientific Committee evaluation, demonstration of free sale certificate routes from reference countries, Arabic labelling and instructions-for-use localization, and the setup of vigilance and periodic reporting systems.
• Service capabilities: product classification and risk grading (devices Class I–III, IVD Class A–D), registration and re-registration, applicability assessment for system registration and bundled registration, three-way variation classification, import approval and annual import plans, and support for vigilance reporting and field safety corrective actions.
• Contact: hito.lin@grzan.cn; website www.grzan.cn.